Ketorolac

Synonyms: 酮咯酸; RS37619
Ketorolac (RS37619) 是一种非甾体抗炎剂,作为非选择性 COX 抑制剂,对 COX-1 和 COX-2 的 IC50 值分别为 20 nM 和 120 nM,其 0.5% 滴眼液被用于过敏性结膜炎、黄斑囊状水肿、术中瞳孔缩小及术后眼炎疼痛的研究,同时它也是一种 DDX3 抑制剂,可用于癌症的研究。
产品编号: MS-L30786 纯度: 99.87% CAS No.: 74103-06-3 分子式: C15H13NO3 分子量: 255.27
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
10mM * 1mL in DMSO
询价
3-5 天
100mg
询价
3-5 天
200mg
询价
询价
500mg
询价
询价

产品描述

Ketorolac (RS37619) 是一种非甾体抗炎剂,作为非选择性 COX 抑制剂,对 COX-1 和 COX-2 的 IC50 值分别为 20 nM 和 120 nM,其 0.5% 滴眼液被用于过敏性结膜炎、黄斑囊状水肿、术中瞳孔缩小及术后眼炎疼痛的研究,同时它也是一种 DDX3 抑制剂,可用于癌症的研究。

生物实验数据

生物活性 Ketorolac (RS37619) is a nonsteroidal anti-inflammatory agent and a non-selective COX inhibitor with IC50 values of 20 nM for COX-1 and 120 nM for COX-2, and its 0.5% ophthalmic solution is used in research on allergic conjunctivitis, cystoid macular edema, intraoperative miosis, and postoperative ocular inflammation pain, while it is also a DDX3 inhibitor that can be used in cancer research.
IC50 & Target COX-2:120 nM , COX-1:20 nM
体外研究
(In Vitro)

Ketorolac (RS37619) salt (0-30 μM; 48 h) effectively kills the oral cancer cells.
Ketorolac salt (0-5 μM; 48 h) inhibits the expression of DDX3 protein, and induces apoptosis in H357 cells.
Ketorolac salt (0-2.5 μM; 0-16 h) inhibits the proliferation of oral cancer cells.
Ketorolac salt (0-50 μM) directly interacts with DDX3 and inhibits the ATPase activity.

Cell Viability Assay

Cell Line: HOK, SCC4, SCC9 and H357 cells
Concentration: 0-30 μM
Incubation Time: 48 h
Result: Showed inhibition with IC50s of 2.6, 7.1 and 8.1 μM against H357, SCC4 and SCC9 cells, respectively. And the normal HOK cell line did not show any cell death effect.

Cell Proliferation Assay

Cell Line: H357
Concentration: 0.5, 1.0, 1.5, 2.0 and 2.5 μM
Incubation Time: 0, 8 and 16 h
Result: Inhibited the proliferation.

Western Blot Analysis

Cell Line: H357
Concentration: 1, 2.5 and 5 μM
Incubation Time: 48 h
Result: Significantly reduced DDX3 protein expression levels, but not completely ablated as compared to DMSO treated cells. Up regulated the expression of E-cadherin.

Apoptosis Analysis

Cell Line: H357
Concentration: 2.5 and 5 μM
Incubation Time: 48 h
Result: Induced apoptosis.
体内研究
(In Vivo)

Ketorolac (RS37619) (0.4% ketorolac tromethamine ophthalmic solution) shows powerful ocular anti-inflammatory activities in rabbits.
Ketorolac (4 mg/kg/day, p.o.; 2 weeks) has no detrimental effect in the volume fraction of bone trabeculae formed inside the alveolar socket in rats.
Ketorolac (60 μg; intrathecal injection; once) attenuates the damage caused by spinal cord ischemia in rats.
Ketorolac salt (20 and 30 mg/kg; i.p.; two times in a week for 3 weeks) reduces oral carcinogenesis in mice.

Animal Model: New Zealand White rabbits (2.0–2.7 kg), LPS endotoxin-induced ocular inflammation
Dosage: 50 μL ketorolac tromethamine ophthalmic solution 0.4%
Administration: In eyes, twice, 2 hours and 1 hour before LPS challenge
Result: Resulted in a nearly complete inhibition (98.7%) of LPS endotoxin-induced increases in FITC (fluorescein isothiocyanate)-dextran in the anterior chamber, and resulted in a nearly complete inhibition (97.5%) of LPS endotoxin-induced increases in aqueous PGE2 concentrations in the aqueous humor.
Animal Model: Male Wistar rats (400–450 g), spinal cord ischemia model
Dosage: 30 and 60 μg
Administration: Intrathecal injection, 1 h before the ischemia induction for once
Result: Significantly reduced the motor disturbances and improved the survival rate at 60 μg.
Animal Model: Significantly reduced the motor disturbances and improved the survival rate at 60 μg.
Dosage: 20 mg/kg and 30 mg/kg
Administration: IP injection, two times in a week for 3 weeks
Result: Decreased tumor burden, reduced expression of DDX3 and anti-apoptotic proteins (Bcl-2 and Mcl-1).
性状 固体
颜色 Light yellow to yellow

化学信息

分子量 255.27
分子式 C15H13NO3
CAS No. 74103-06-3
别名 酮咯酸; RS37619

储存&溶解度

储存方式

4°C, sealed storage, away from moisture

*In solvent: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

运输条件 Room temperature in continental US; may vary elsewhere.
溶液配制表

DMSO 中的溶解度 : 200 mg/mL (783.48 mM; 超声助溶; 吸湿的 DMSO 对产品的溶解度有显著影响,请使用新开封的 DMSO)

可选溶剂浓度1 mg5 mg10 mg25 mg
DMSO1 mM3.9174 mL19.5871 mL39.1742 mL97.9355 mL
5 mM0.7835 mL3.9174 mL7.8348 mL19.5871 mL
10 mM0.3917 mL1.9587 mL3.9174 mL9.7936 mL
15 mM0.2612 mL1.3058 mL2.6116 mL6.5290 mL
20 mM0.1959 mL0.9794 mL1.9587 mL4.8968 mL
25 mM0.1567 mL0.7835 mL1.5670 mL3.9174 mL
30 mM0.1306 mL0.6529 mL1.3058 mL3.2645 mL
40 mM0.0979 mL0.4897 mL0.9794 mL2.4484 mL
50 mM0.0783 mL0.3917 mL0.7835 mL1.9587 mL
60 mM0.0653 mL0.3265 mL0.6529 mL1.6323 mL
80 mM0.0490 mL0.2448 mL0.4897 mL1.2242 mL
100 mM0.0392 mL0.1959 mL0.3917 mL0.9794 mL

* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)。-80°C储存时,请在6个月内使用,-20°C储存时,请在1个月内使用。

该溶液配制表仅适用于固体产品。对于液体产品,请根据标明的浓度或密度计算稀释方案。

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础